A detailed history of Clarity Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Clarity Wealth Advisors, LLC holds 363 shares of LLY stock, worth $274,065. This represents 0.09% of its overall portfolio holdings.

Number of Shares
363
Previous 241 50.62%
Holding current value
$274,065
Previous $218,000 47.25%
% of portfolio
0.09%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$772.14 - $960.02 $94,201 - $117,122
122 Added 50.62%
363 $321,000
Q2 2024

Jul 17, 2024

BUY
$724.87 - $909.04 $174,693 - $219,078
241 New
241 $218,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Clarity Wealth Advisors, LLC Portfolio

Follow Clarity Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarity Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarity Wealth Advisors, LLC with notifications on news.